mobile

News

French tech company Kayentis has raised €7 million in private funding that will be invested in its digital platform for clinical trials.

Digital

Heads of innovation, communication and digital strategy in pharma reflected at Frontiers Health 2018 on the implications of technological changes.

News

Teva has made its first pipeline-building acquisition in almost a decade, buying Tourette syndrome drug developer Emalex for up to $900m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.